Pharmaceutical and diagnostics giant Roche has recently integrated a suite of AI algorithms into its enterprise digital pathology software.
The company has collaborated with South Korean firm Deep Bio to power the navify digital pathology platform with the prostate cancer analysis AI solution, DeepDx Prostate. The AI technology provides pathologists with gland-level Gleason grading, measurements...
Singapore-headquartered Qritive has integrated its AI modules with US-based Corista's image management platform DP3.
According to a press statement, the combined solution leverages AI to screen for both prostate and colon cancers, quantify IHC markers, and detect lymph node metastasis.
It allows pathologists to prioritise and grade specific cases while improving the detection of hard-to-...
Medical AI startup Qritive has pooled $7.5 million in a funding round led by MassMutual Ventures and supported by Enterprise Singapore's investment arm SEEDS Capital and Exfinity Venture Partners.
WHAT IT DOES
Founded in 2017, the Singapore-headquartered company offers diagnostic support solutions that provide fast and accurate pathological interpretations "within seconds." Its digital pathology...
